34 results on '"Wagner, Anita Katharina"'
Search Results
2. Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021
3. Costs and effectiveness of the supervision, performance assessment and recognition (SPARS) strategy for medicines management in Uganda
4. Improving Access to High-Cost Medicines in Low Income Countries in Africa: Creating a Functioning Pharmaceutical System in Uganda
5. Contributors
6. Pharmaceutical system strengthening in Uganda: implementing a holistic, evidence-informed, long-term strategy
7. Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database
8. Can locally developed me-too drugs aid price negotiation? An example of cancer therapies from China
9. Financial Pollution in the US Health Care System
10. Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
11. The Effectiveness of Enhanced Primary Healthcare (EnPHC) Interventions on Type 2 Diabetes Management in Malaysia: Difference-in-differences (DID) Analysis
12. What are the volume and budget needs to provide chemotherapy to all children with acute lymphoblastic leukaemia in Thailand? Development and application of an estimation tool
13. Impacts of Government Reimbursement Negotiation on Targeted Anticancer Medication Price, Volume and Spending in China
14. Differences in reimbursement listing of anticancer therapies in China: an observational study
15. Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study
16. Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database
17. Chapter 8 - Improving Access to High-Cost Medicines in Low Income Countries in Africa: Creating a Functioning Pharmaceutical System in Uganda
18. Differences in reimbursement listing of anticancer therapies in China: an observational study.
19. Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study.
20. Competency in supportive supervision: a study of public sector medicines management supervisors in Uganda
21. Improving Access to Medicines in Low and Middle Income Countries: Corporate Responsibilities in Context
22. Article 1: Supervision, Performance Assessment, and Recognition Strategy (SPARS) - a multipronged intervention strategy for strengthening medicines management in Uganda: method presentation and facility performance at baseline
23. Prescribing for acute childhood infections in developing and transitional countries, 1990–2009
24. Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study
25. Prescribing for acute childhood infections in developing and transitional countries, 1990-2009.
26. Need for and Access to Health Care and Medicines: Are There Gender Inequities?
27. Evaluating Quality of Care for Patients with Type 2 Diabetes Using Electronic Health Record Information in Mexico
28. Measuring Adherence to Antiretroviral Treatment in Resource-poor Settings: The Clinical Validity of Key Indicators
29. Availability and Use of Essential Medicines in China: Manufacturing, Supply, and Prescribing in Shandong and Gansu Provinces
30. Medicines Coverage and Community-Based Health Insurance in Low-Income Countries
31. A Descriptive Review of the Methodologies Used in Household Surveys on Medicine Utilization
32. Costs of Hospital Care for Hypertension in an Insured Population Without an Outpatient Medicines Benefit: An Observational Study in the Philippines
33. Benzodiazepine Use and Hip Fractures in the Elderly
34. Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.